SLM produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding

International Journal of Molecular Sciences

Volumn 16, Issue 4, 2015, Pages 7478-7492

  Matena, Julia ^a   Petersen, Svea ^b   Gieseke, Matthias ^c   Kampmann, Andreas ^d   Teske, Michael ^b   Beyerbach, Martin ^a   Escobar, Hugo Murua ^a,e   Haferkamp, Heinz ^f   Gellrich, Nils Claudius ^d   Nolte, Ingo ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c LASER ZENTRUM HANNOVER E V   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY OF ROSTOCK   (Germany)

^f LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Cell migration; Cross section; CXCL12; HMGB1; Live cell imaging; Osteoblast; Polycaprolactone; Selective laser melting; Titanium implant; VEGF

Indexed keywords

GREEN FLUORESCENT PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; POLYCAPROLACTONE; STROMAL CELL DERIVED FACTOR 1; TITANIUM; VASCULOTROPIN; POLYESTER; POLYMER; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL SPREADING; FLUORESCENCE MICROSCOPY; IMPLANT; MELTING POINT; MOUSE; NONHUMAN; OSTEOBLAST; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SELECTIVE LASER MELTING; TITANIUM IMPLANT; TITANIUM POLYCAPROLACTONE IMPLANT; VASCULARIZATION; ANGIOGENESIS; ANIMAL; BLOOD VESSEL; BONE DEVELOPMENT; C57BL MOUSE; CELL ADHESION; CELL CULTURE; CELL MOTION; CHEMISTRY; DRUG EFFECTS; ENDOTHELIUM CELL; FREEZING; LASER; METABOLISM; POROSITY; PROSTHESES AND ORTHOSES; SURFACE PROPERTY;

ANIMALS; BLOOD VESSELS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; FREEZING; HMGB1 PROTEIN; LASERS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOGENESIS; POLYESTERS; POLYMERS; POROSITY; PROSTHESES AND IMPLANTS; SURFACE PROPERTIES; TITANIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84927672516     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16047478     Document Type: Article

References (45)

1. Thijs, L.; Verhaeghe, F.; Craeghs, T.; Humbeeck, J.V.; Kruth, J.-P. A study of the microstructural evolution during selective laser melting of Ti-6Al-4V. Acta Mater. 2010, 58, 3303-3312.
2. Kruth, J.P.; Froyen, L.; van Vaerenbergh, J.; Mercelis, P.; Rombouts, M.; Lauwers, B. Selective laser melting of iron-based powder. J. Mater. Proc. Technol. 2004, 149, 616-622.
3. Murray, J.L.; Wriedt, H.A. The O-Ti (oxygen-titanium) system. JPE 1987, 8, 148-165.
4. Louvis, E.; Fox, P.; Sutcliffe, C.J. Selective laser melting of aluminium components. J. Mater. Proc. Technol. 2011, 211, 275-284.
5. Vandenbroucke, B.; Kruth, J.P. Selective laser melting of biocompatible metals for rapid manufacturing of medical parts. Rapid Prototyp. J. 2007, 13, 196-203.
6. Van Bael, S.; Chai, Y.C.; Truscello, S.; Moesen, M.; Kerckhofs, G.; van Oosterwyck, H.; Kruth, J.P.; Schrooten, J. The effect of pore geometry on the in vitro biological behavior of human periosteum-derived cells seeded on selective laser-melted Ti6Al4V bone scaffolds. Acta Biomater. 2012, 8, 2824-2834.
7. Fukuda, A.; Takemoto, M.; Saito, T.; Fujibayashi, S.; Neo, M.; Pattanayak, D.K.; Matsushita, T.; Sasaki, K.; Nishida, N.; Kokubo, T.; et al. Osteoinduction of porous ti implants with a channel structure fabricated by selective laser melting. Acta Biomater. 2011, 7, 2327-2336.
8. Van der Stok, J.; van der Jagt, O.P.; Yavari, S.A.; de Haas, M.F.; Waarsing, J.H.; Jahr, H.; van Lieshout, E.M.; Patka, P.; Verhaar, J.A.; Zadpoor, A.A.; et al. Selective laser melting-produced porous titanium scaffolds regenerate bone in critical size cortical bone defects. J. Orthop. Res. 2013, 31, 792-799.
9. Loh, Q.L.; Choong, C. Three-dimensional scaffolds for tissue engineering applications: Role of porosity and pore size. Tissue Eng. 2013, 19, 485-502.
10. Muller, D.; Chim, H.; Bader, A.; Whiteman, M.; Schantz, J.T. Vascular guidance: Microstructural scaffold patterning for inductive neovascularization. Stem Cells Int. 2010, 2011, 547247.
11. Saran, U.; Gemini Piperni, S.; Chatterjee, S. Role of angiogenesis in bone repair. Arch. Biochem. Biophys. 2014, 561, 109-117.
12. Artel, A.; Mehdizadeh, H.; Chiu, Y.C.; Brey, E.M.; Cinar, A. An agent-based model for the investigation of neovascularization within porous scaffolds. Tissue Eng. 2011, 17, 2133-2141.
13. Lindhorst, D.; Tavassol, F.; von See, C.; Schumann, P.; Laschke, M.W.; Harder, Y.; Bormann, K.H.; Essig, H.; Kokemuller, H.; Kampmann, A.; et al. Effects of vegf loading on scaffold-confined vascularization. J. Biomed. Mater. Res. 2010, 95, 783-792.
14. Ring, A.; Langer, S.; Homann, H.H.; Kuhnen, C.; Schmitz, I.; Steinau, H.U.; Drucke, D. Analysis of neovascularization of PEGT/PBT-copolymer dermis substitutes in balb/c-mice. Burns 2006, 32, 35-41.
15. Ferrara, N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr. Rev. 2004, 25, 581-611.
16. Wake, H.; Mori, S.; Liu, K.; Takahashi, H.K.; Nishibori, M. High mobility group box 1 complexed with heparin induced angiogenesis in a matrigel plug assay. Acta Med. Okayama 2009, 63, 249-262.
17. Kew, R.R.; Penzo, M.; Habiel, D.M.; Marcu, K.B. The IKKα-dependent Nf-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. J. Immunol. 2012, 188, 2380-2386.
18. De Giglio, E.; Cometa, S.; Ricci, M.A.; Zizzi, A.; Cafagna, D.; Manzotti, S.; Sabbatini, L.; Mattioli-Belmonte, M. Development and characterization of rhVEGF-loaded poly(HEMA-MOEP) coatings electrosynthesized on titanium to enhance bone mineralization and angiogenesis. Acta Biomater. 2010, 6, 282-290.
19. Fu, Y.; Zhang, Q.; Sun, Y.; Liao, W.; Bai, X.; Zhang, L.; Du, L.; Jin, Y.; Wang, Q.; Li, Z.; et al. Controlled-release of bone morphogenetic protein-2 from a microsphere coating applied to acid-etched Ti6Al4V implants increases biological bone growth in vivo. J. Orthop. Res. 2014, 32, 744-751.
20. Wulf, K.; Teske, M.; Lobler, M.; Luderer, F.; Schmitz, K.P.; Sternberg, K. Surface functionalization of poly(epsilon-caprolactone) improves its biocompatibility as scaffold material for bioartificial vessel prostheses. J. Biomed. Mater. Res. 2011, 98, 89-100.
21. Cipitria, A.; Reichert, J.C.; Epari, D.R.; Saifzadeh, S.; Berner, A.; Schell, H.; Mehta, M.; Schuetz, M.A.; Duda, G.N.; Hutmacher, D.W. Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae. Biomaterials 2013, 34, 9960-9968.
22. Dash, T.K.; Konkimalla, V.B. Poly-ε-caprolactone based formulations for drug delivery and tissue engineering: A review. J. Control. Release 2012, 158, 15-33.
23. El-Hajje, A.; Kolos, E.C.; Wang, J.K.; Maleksaeedi, S.; He, Z.; Wiria, F.E.; Choong, C.; Ruys, A.J. Physical and mechanical characterisation of 3D-printed porous titanium for biomedical applications. J. Mater. Sci. Mater. Med. 2014, 25, 2471-2480.
24. Udroiu, R. Powder bed additive manufacturing systems and its applications. Acad. J. Manuf. Eng. 2012, 10, 122-129.
25. Murr, L.E.; Quinones, S.A.; Gaytan, S.M.; Lopez, M.I.; Rodela, A.; Martinez, E.Y.; Hernandez, D.H.; Martinez, E.; Medina, F.; Wicker, R.B. Microstructure and mechanical behavior of Ti-6Al-4V produced by rapid-layer manufacturing, for biomedical applications. J. Mech. Behav. Biomed. Mater. 2009, 2, 20-32.
26. Kumara, S.; Pityanab, S. Laser-based additive manufacturing of metals. Adv. Mater. Res. 2011, 227, 4.
27. Lewis, G. Properties of open-cell porous metals and alloys for orthopaedic applications. J. Mater. Sci. Mater. Med. 2013, 24, 2293-2325.
28. Yavari, S.A.; van der Stok, J.; Chai, Y.C.; Wauthle, R.; Tahmasebi Birgani, Z.; Habibovic, P.; Mulier, M.; Schrooten, J.; Weinans, H.; Zadpoor, A.A. Bone regeneration performance of surface-treated porous titanium. Biomaterials 2014, 35, 6172-6181.
29. Muller, U.; Imwinkelried, T.; Horst, M.; Sievers, M.; Graf-Hausner, U. Do human osteoblasts grow into open-porous titanium? Eur. Cells Mater. 2006, 11, 8-15.
30. Van der Stok, J.; Wang, H.; Amin Yavari, S.; Siebelt, M.; Sandker, M.; Waarsing, J.H.; Verhaar, J.A.; Jahr, H.; Zadpoor, A.A.; Leeuwenburgh, S.C.; et al. Enhanced bone regeneration of cortical segmental bone defects using porous titanium scaffolds incorporated with colloidal gelatin gels for time-and dose-controlled delivery of dual growth factors. Tissue Eng. 2013, 19, 2605-2614.
31. Laschke, M.W.; Rucker, M.; Jensen, G.; Carvalho, C.; Mulhaupt, R.; Gellrich, N.C.; Menger, M.D. Improvement of vascularization of PLGA scaffolds by inosculation of in situ-preformed functional blood vessels with the host microvasculature. Ann. Surg. 2008, 248, 939-948.
32. Mitola, S.; Belleri, M.; Urbinati, C.; Coltrini, D.; Sparatore, B.; Pedrazzi, M.; Melloni, E.; Presta, M. Cutting edge: Extracellular high mobility group box-1 protein is a proangiogenic cytokine. J. Immunol. 2006, 176, 12-15.
33. Palumbo, R.; Sampaolesi, M.; de Marchis, F.; Tonlorenzi, R.; Colombetti, S.; Mondino, A.; Cossu, G.; Bianchi, M.E. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 2004, 164, 441-449.
34. Zachary, I. Vegf signalling: Integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 2003, 31, 1171-1177.
35. Poh, C.K.; Shi, Z.; Lim, T.Y.; Neoh, K.G.; Wang, W. The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 2010, 31, 1578-1585.
36. Palumbo, R.; Galvez, B.G.; Pusterla, T.; De Marchis, F.; Cossu, G.; Marcu, K.B.; Bianchi, M.E. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation. J. Cell Biol. 2007, 179, 33-40.
37. Schiraldi, M.; Raucci, A.; Munoz, L.M.; Livoti, E.; Celona, B.; Venereau, E.; Apuzzo, T.; de Marchis, F.; Pedotti, M.; Bachi, A.; et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med. 2012, 209, 551-563.
38. Xiao, Y.; Yuan, M.; Zhang, J.; Yan, J.; Lang, M. Functional poly(epsilon-caprolactone) based materials: Preparation, self-assembly and application in drug delivery. Curr. Top. Med. Chem. 2014, 14, 781-818.
39. Niu, X.; Yang, C.; Chen, D.; He, S.; Yan, D.; Yao, Y. Impact of drug-eluting stents with different coating strategies on stent thrombosis: A meta-analysis of 19 randomized trials. Cardiol. J. 2014, 21, 557-568.
40. Galli, C.; Piergianni, M.; Piemontese, M.; Lumetti, S.; Ravanetti, F.; Cacchioli, A.; Macaluso, G.M.; Passeri, G. Periostin improves cell adhesion to implantable biomaterials and osteoblastic differentiation on implant titanium surfaces in a topography-dependent fashion. J. Biomed. Mater. Res. 2014, 102, 3855-3861.
41. Sola-Ruiz, M.F.; Perez-Martinez, C.; Martin-Del-Llano, J.J.; Carda-Batalla, C.; Labaig-Rueda, C. In vitro preliminary study of osteoblast response to surface roughness of titanium discs and topical application of melatonin. Med. Oral Patol. Oral Cir. Bucal 2015, 20, e88-e93.
42. Sheikh, F.; Barakat, N.M.; Kanjwal, M.; Aryal, S.; Khil, M.; Kim, H.-Y. Novel self-assembled amphiphilic poly(ε-caprolactone)-grafted-poly(vinyl alcohol) nanoparticles: Hydrophobic and hydrophilic drugs carrier nanoparticles. J. Mater. Sci: Mater. Med. 2009, 20, 821-831.
43. Brynda, E.; Pachernik, J.; Houska, M.; Pientka, Z.; Dvorak, P. Surface immobilized protein multilayers for cell seeding. Langmuir 2005, 21, 7877-7883.
44. Williams, J.M.; Adewunmi, A.; Schek, R.M.; Flanagan, C.L.; Krebsbach, P.H.; Feinberg, S.E.; Hollister, S.J.; Das, S. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 2005, 26, 4817-4827.
45. Chen, X.D.; Qian, H.Y.; Neff, L.; Satomura, K.; Horowitz, M.C. Thy-1 antigen expression by cells in the osteoblast lineage. J. Bone Miner. Res. 1999, 14, 362-375.